2018-12-03 09:29
For full program and registration, see link: http://www.introduce.se/artiklar/2018/10/introduce-investor-day---v3/. The event will also be livestreamed at introduce.se. More information: Anders Rylander, CEO Biovica. Phone: +46 (0)18 444 48 35, E-mail...
2018-11-30 11:32
How to participate: The live webcast and a recorded on-demand version including the presentation material will be accessible at: https://tv.streamfabriken.com/biovica-international-q2-2018 Questions can be asked in writing via the webcast or verbally...
2018-11-28 09:15
Palbociclib is a successful targeted drug from Pfizer for patients with metastatic breast cancer. The drug was launched in 2015 and is currently selling for >$2 billion per year. Currently, no biomarkers are used for prognosis and monitoring of patients...
2018-11-07 13:34
The event be webcasted on www.aktiespararna.se/tv/live. The presentation will be available on the company’s website after the presentation. For full program and registration, see link: www.aktiespararna.se/aktiviteter/stora-aktiedagen-goteborg-2018...
2018-09-28 08:00
During his time as President and CEO of cancer diagnostic company Dako, Lars Holmqvist reformed the company to become a complete and highly competitive diagnostics company in its market segments. Lars also contributed to EQT selling Dako to Agilent Technologies...
2018-09-06 08:00
He holds a Ph.D. in clinical immunology from Uppsala University. Wing is leaving the role as Manager Clinical Utility at Thermo Fisher. Wing also has background from national and European authorities in the regulatory and reimbursement area, e.g. The...
2018-08-30 18:36
Below is a summary of the decisions taken at the Annual General Meeting, AGM. The Meeting resolved that available funds of SEK 60,768,811 will be carried forward. The Meeting resolved that Board members should be compensated with SEK 125,000 for Directors...
2018-08-27 08:00
Biovica has previously communicated about a completed pre-submission to the FDA where risk class (II) and type of process (510(k) pre-market notification) were defined. Today, the company reports that also the next step in the process, supplementary 1...
2018-08-23 11:00
”It is important for Biovica to protect our unique technology. Hence, it is positive news that we get improved patent protection on one of the more important markets. Patent protection is important in order to be able to bring our products to the...
2018-08-15 08:30
Biovica and WntResearch acknowledge the possibility to utilize a blood sample to identify patients that will benefit from Foxy-5. The rationale for the collaboration are several studies demonstrating that thymidine kinase (TK) activity can be measured...
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects